Biogen Idec Company Profile

Aggregated data from the web about Biogen Idec

Company Name	Biogen Idec
Website	https://en.wikipedia.org
Snippet	In 2003, Biogen merged with San Diego, California-based IDEC Pharmaceuticals (formed in 1985 by University of California-San Diego's physicians and immunologists Ivor Royston and Robert E. Sobol, San Diego bio entrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller) and adopted the name Biogen Idec.
Type	Public
Founded	1978
Revenue	US$12.274 billion (2017)[1]
Website	biogen.com
Formerly	Biogen Idec Inc. (2003–2015)
Founders	Kenneth MurrayPhillip Allen SharpWalter GilbertHeinz Schaller Charles Weissmann
Industry	Biotechnology
Products	Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza
Traded as	NASDAQ: BIIB, NASDAQ-100 component, S&P 100 component, S&P 500 component
Key people	Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO)
Net income	US$2.539 billion (2017)[1]
Headquarters	Cambridge, Massachusetts, U.S.
Total assets	US$23.653 billion (2017)[1]
Total equity	US$12.613 billion (2017)[1]
Operating income	US$5.344 billion (2017)[1]
Number of employees	~7,300 (December 2017)[1]

Biogen Idec is part of the United States company list

Biogen Idec is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.